These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

904 related articles for article (PubMed ID: 12061429)

  • 21. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
    Pay S; Erdem H; Pekel A; Simsek I; Musabak U; Sengul A; Dinc A
    Rheumatol Int; 2006 May; 26(7):608-13. PubMed ID: 16205926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on the relationship between the level of cytokine and liver function in patients with clonorchiasis sinensis].
    Cai LS; Xiao JY; Xin H; Zhu LX; Chen G; Zhang T; Wang GZ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Feb; 22(1):54-6. PubMed ID: 15283270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?
    Sadeghi M; Daniel V; Naujokat C; Weimer R; Opelz G
    Clin Exp Immunol; 2005 Nov; 142(2):312-7. PubMed ID: 16232218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.
    Mege JL; Dilsen N; Sanguedolce V; Gul A; Bongrand P; Roux H; Ocal L; Inanç M; Capo C
    J Rheumatol; 1993 Sep; 20(9):1544-9. PubMed ID: 8164212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients.
    Baykal Y; Saglam K; Yilmaz MI; Taslipinar A; Akinci SB; Inal A
    Clin Rheumatol; 2003 May; 22(2):99-101. PubMed ID: 12740672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-alpha level in patients with mucocutaneous type of Behcet's disease.
    Sun A; Wang YP; Chia JS; Liu BY; Chiang CP
    J Oral Pathol Med; 2009 May; 38(5):401-5. PubMed ID: 19434815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression.
    Liu Y; Ho RC; Mak A
    J Affect Disord; 2012 Aug; 139(3):230-9. PubMed ID: 21872339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
    Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation.
    De Gennaro L; Brunetti ND; Montrone D; De Rosa F; Cuculo A; Di Biase M
    Eur J Clin Invest; 2012 Apr; 42(4):371-5. PubMed ID: 21913917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid peroxidation and homocysteine levels in Behçet's disease.
    Mungan AG; Can M; Açikgöz S; Eştürk E; Altinyazar C
    Clin Chem Lab Med; 2006; 44(9):1115-8. PubMed ID: 16958606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
    Grüngreiff K; Reinhold D; Ansorge S
    Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease.
    Hamzaoui K; Hamzaoui A; Ghorbel I; Khanfir M; Houman H
    Scand J Immunol; 2006 Dec; 64(6):655-60. PubMed ID: 17083622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum paraoxonase activity is decreased in the active stage of Behçet's disease.
    Karakucuk S; Baskol G; Oner AO; Baskol M; Mirza E; Ustdal M
    Br J Ophthalmol; 2004 Oct; 88(10):1256-8. PubMed ID: 15377545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
    Lauerová L; Dusek L; Simícková M; Rovný F; Spurný V; Rovný A; Slampa P; Zaloudík J; Rejthar A; Wotke J; Kovarík J
    Neoplasma; 1999; 46(3):141-9. PubMed ID: 10613588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of tripterygium glycosides on serum interleukin-1beta, interleukin-2, tumor necrosis factor alpha, and interferon-gamma levels in patients with Behcet's disease].
    Song Q; Lu JZ; Li J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):598-600. PubMed ID: 20815274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
    Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
    Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.